Olaplex Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olaplex Holdings, Inc. - OLPX
Kahn Swick & Foti, LLC is investigating the proposed sale of Olaplex Holdings, Inc. (NasdaqGS: OLPX) to Henkel AG & Co. KGaA. The law firm is examining whether the proposed cash consideration of $2.06 per share adequately values Olaplex and the fairness of the sale process. Shareholders who believe the transaction undervalues the company are encouraged to contact KSF to discuss their legal rights.
Olaplex Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olaplex Holdings, Inc. - OLPX
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Olaplex Holdings, Inc. (NasdaqGS: OLPX) to Henkel AG & Co. KGaA. The law firm is examining whether the offered price of $2.06 per share adequately values Olaplex and is encouraging shareholders who believe the transaction undervalues the company to contact them for legal consultation. KSF's investigation focuses on the fairness of the consideration and the process leading to the proposed sale.
Olaplex Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olaplex Holdings, Inc. - OLPX
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Olaplex Holdings, Inc. (NasdaqGS: OLPX) to Henkel AG & Co. KGaA for $2.06 per share. The law firm is assessing whether this cash consideration and the transaction process are fair to shareholders or if the Company is undervalued. KSF is inviting Olaplex shareholders who believe the offer undervalues the company to contact them to discuss their legal rights.
Brodsky & Smith Investigating Olaplex Holdings - Bala Cynwyd Today
Brodsky & Smith, a law firm specializing in shareholder rights, has launched an investigation into Olaplex Holdings, Inc., a cosmetics company. The probe aims to assess potential breaches of fiduciary duty by Olaplex's officers and directors following concerns from shareholders about financial performance and management decisions. This investigation underscores the importance of strong corporate governance and transparency as such actions can significantly impact a company's operations, reputation, and stock price.
OLPX Should I Buy
Olaplex Holdings Inc (OLPX) is not recommended as a good buy for beginner long-term investors due to it trading near its acquisition price of $2.06, which limits upside potential. Technical indicators suggest the stock is overbought, despite recent improvements in financial performance like a 4.35% YoY revenue increase and 48.89% YoY net income improvement in Q4 2025. Analysts have mixed views, with some downgrading to Hold, and the average target price is $1.84, below the current trading price of $2.03.
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Olaplex Holdings, Inc. (Nasdaq – OLPX)
Brodsky & Smith is investigating potential claims against Olaplex Holdings, Inc.'s Board of Directors regarding the company's sale to Henkel AG & Co. KGaA for $2.06 per share. The law firm is examining whether the Board fulfilled its fiduciary duties by failing to conduct a fair process and ensure fair value for shareholders. Shareholders of Olaplex stock are invited to contact Brodsky & Smith to discuss the investigation.
Brodsky & Smith Investigating Olaplex Acquisition by Henkel
Brodsky & Smith is investigating the proposed acquisition of Olaplex Holdings by Henkel AG & Co. KGaA for approximately $1.4 billion. The law firm is probing whether Olaplex's Board of Directors breached its fiduciary duties to shareholders by potentially failing to ensure a fair process and value in the $2.06 per share cash deal. The investigation aims to determine if shareholders are receiving the best possible deal for their investment.
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Olaplex Holdings, Inc. (Nasdaq – OLPX)
Brodsky & Smith LLC is investigating potential claims against the Board of Directors of Olaplex Holdings, Inc. (Nasdaq – OLPX) following its acquisition by Henkel AG & Co. KGaA for $2.06 per share. The investigation focuses on whether Olaplex's Board breached its fiduciary duties to shareholders by not conducting a fair process and ensuring fair value for the Company. Shareholders are invited to contact Brodsky & Smith for a discussion of the legal implications.
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--WBD, EQH, CRBG, and OLPX
Monteverde & Associates PC, a class action firm, is investigating potential mergers and acquisitions for Warner Bros. Discovery, Inc. (WBD), Equitable Holdings, Inc. (EQH), Corebridge Financial, Inc. (CRBG), and Olaplex Holdings, Inc. (OLPX). The firm encourages shareholders of these companies to contact them for a free case evaluation, emphasizing its track record in recovering funds for shareholders. Specifically, they are looking into the sale of WBD to Paramount Skydance, the merger between EQH and CRBG, and the sale of OLPX to Henkel US Operations Corporation.
OLPX Stock Alert: Halper Sadeh LLC is Investigating Whether Olaplex Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Olaplex Holdings, Inc. (NASDAQ: OLPX) to Henkel AG & Co. KGaA for $2.06 per share. The investigation aims to determine if Olaplex and its board violated federal securities laws or breached fiduciary duties by failing to secure the best price for shareholders, conduct a fair sales process, or disclose all material information. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief for shareholders.
OLPX Stock Alert: Halper Sadeh LLC is Investigating Whether Olaplex Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC is investigating whether Olaplex Holdings, Inc. (NASDAQ: OLPX) is obtaining a fair price for its shareholders in its sale to Henkel AG & Co. KGaA for $2.06 per share. The investigation centers on whether Olaplex and its board of directors breached their fiduciary duties by failing to secure the best possible price, conduct a fair sales process, and disclose all material information to shareholders. Halper Sadeh LLC encourages shareholders to contact them to learn more about their rights and options.
OLPX Stock Alert: Halper Sadeh LLC is Investigating Whether Olaplex Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC is investigating the sale of Olaplex Holdings, Inc. (NASDAQ: OLPX) to Henkel AG & Co. KGaA for $2.06 per share. The investigation focuses on whether Olaplex's board failed to secure the best possible price for shareholders, conducted a fair sales process, and disclosed all material information. Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options.
Olaplex Holdings, Inc. Common Stock (OLPX) Stock Price Today & Analysis
Olaplex Holdings, Inc. is a science-enabled beauty company focused on improving hair health through proprietary technology. The article provides current stock price data for OLPX, including financial fundamentals, valuation metrics, and dividend information. It also offers a FAQ on how to buy OLPX stock, minimum investment amounts, and market hours via the Gotrade app.
How $1.4bn Olaplex Acquisition Boosts Henkel’s Portfolio
Henkel AG is acquiring luxury haircare brand Olaplex Holdings Inc. for US$1.4bn, a move expected to expand Henkel's premium haircare portfolio and Olaplex's international reach and innovation opportunities. This acquisition follows Olaplex's struggle to maintain its public company valuation since its 2021 IPO, having lost nearly 95% of its stock value. The deal is part of Henkel's "purposeful growth" agenda, complementing a recent acquisition of Not Your Mother’s, and aims to strengthen its position in the global haircare market.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Olaplex Holdings, Inc. (NASDAQ: OLPX)
Monteverde & Associates PC is investigating Olaplex Holdings, Inc. (NASDAQ: OLPX) in relation to its proposed acquisition by Henkel US Operations Corporation, where Olaplex shareholders would receive $2.06 per share in cash. The M&A Class Action Firm, recognized for recovering millions for shareholders, is questioning the fairness of this deal. Shareholders are encouraged to contact Juan Monteverde for more information regarding their rights.
Olaplex Holdings, Inc. (NASDAQ:OLPX) Receives Average Rating of "Hold" from Analysts
Olaplex Holdings, Inc. (NASDAQ:OLPX) has received an average "Hold" rating from analysts, with a mean 1-year target price of $1.8786, which is below the recent takeover offer. Henkel's agreement to acquire Olaplex for $2.06 per share, a 55% premium, has driven the stock surge, although insider sales and a shareholder investigation into the deal's fairness introduce potential risks. The company recently reported earnings that met analyst expectations, with revenue up 4.4% year-over-year.
Shareholder Alert: The Ademi Firm investigates whether Olaplex Holdings Inc. is obtaining a Fair Price for Public Shareholders
Ademi LLP is investigating Olaplex (NASDAQ: OLPX) for potential breaches of fiduciary duty due to its recently announced transaction with Henkel, where stockholders will receive $2.06 per share cash, valuing the deal at approximately $1.4 billion. The firm is concerned that the transaction agreement may unfairly limit competing offers and questions whether the Olaplex board is fulfilling its duties to all shareholders, especially since insiders stand to benefit substantially. Shareholders are invited to join the investigation.
Henkel to acquire hair care company Olaplex for $1.4 billion equity value
Henkel AG & Co. has agreed to acquire New York-based hair care company Olaplex Holdings for an equity value of approximately $1.4 billion. The deal is expected to close in the second half of 2026. This acquisition involves a leading, science-led prestige hair care brand.
Olaplex to Be Acquired by Henkel for $2.06 Per Share in All-Cash Merger
Olaplex announced that it will be acquired by Henkel US Operations for $2.06 per share in an all-cash merger. Principal stockholders representing approximately 75% of shares have already provided consent for the deal. This agreement also includes a waiver to terminate Olaplex's Tax Receivable Agreement to streamline the closing process.
Henkel to buy Olaplex (NASDAQ: OLPX) in $1.4B all-cash takeover
Henkel is set to acquire Olaplex (NASDAQ: OLPX) in an all-cash deal valued at approximately $1.4 billion, paying $2.06 per share. This represents a significant premium of about 55% over Olaplex’s prior closing price. The transaction, which has already received written consent from major shareholder Advent-affiliated funds, is expected to close in the second half of 2026, subject to regulatory approvals, and will result in Olaplex becoming a wholly owned subsidiary of Henkel and delisted from Nasdaq.
Olaplex Holdings garners Wall Street attention amid Henkel's $1.4 billion acquisition deal
Olaplex Holdings is attracting increased Wall Street attention following Henkel's acquisition of a brand for $1.4 billion. Analysts are speculating on Olaplex's potential as an acquisition target or the impact on its market valuation due to similar industry dynamics. This development suggests a shift in investor sentiment and strategic positioning within the beauty and personal care sector.
Olaplex Holdings Garners Wall Street Attention Amid Henkel's $1.4 Billion Acquisition Deal
Olaplex Holdings received significant attention from Wall Street after announcing its acquisition by Henkel for $2.06 per share in a $1.4 billion cash transaction. Following the announcement, several analysts downgraded Olaplex stock, with Canaccord moving it to "Hold" and Northland to "Market Perform," while Evercore ISI lowered its price target. Despite the downgrades, Olaplex's stock surged more than 50% on the news, reflecting a premium for shareholders.
OLAPLEX to Join Henkel in $1.4B Hair-Care Power Move
Henkel Corp. is set to acquire OLAPLEX Holdings Inc. in a $1.4 billion cash deal, expected to close by the end of 2026. This acquisition aims to combine OLAPLEX’s premium hair-care brand with Henkel’s global scale, accelerating international expansion and innovation in the beauty market. OLAPLEX stockholders will receive $2.06 per share, and the company will continue to operate under its existing brand name but will be delisted from Nasdaq.
Shareholder Alert: The Ademi Firm investigates whether Olaplex Holdings Inc. is obtaining a Fair Price for Public Shareholders
Ademi LLP is investigating Olaplex Holdings Inc. (NASDAQ: OLPX) for potential breaches of fiduciary duty related to its recently announced cash transaction with Henkel, valued at approximately $1.4 billion. The firm is concerned that the $2.06 per share offered to stockholders may not constitute a fair price and that the transaction agreement unreasonably limits competing bids. Ademi LLP is examining the conduct of Olaplex's board of directors to ensure they are fulfilling their fiduciary duties to all shareholders.
Shareholder Alert: The Ademi Firm investigates whether Olaplex Holdings Inc. is obtaining a Fair Price for Public Shareholders
Ademi LLP is investigating Olaplex Holdings Inc. (NASDAQ: OLPX) for potential breaches of fiduciary duty related to its recently announced $1.4 billion cash transaction with Henkel, where stockholders will receive $2.06 per share. The firm is examining whether the Olaplex board fulfilled its duties to all shareholders, particularly given the benefits received by insiders and the significant penalty clause for competing bids. Shareholders are encouraged to join the investigation.
Olaplex Stock Remains Volatile Amid Financial Performance Uncertainties
Olaplex Holdings Inc. (NASDAQ: OLPX) stock has seen significant volatility, trading up by 50.38 percent despite premarket declines. The company exceeded fourth-quarter earnings and revenue expectations, projecting solid figures for fiscal year 2026. However, increased marketing spend and competitive pressures are eroding profit margins, contributing to investor skepticism.
Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday
Olaplex Holdings, Kodiak Sciences, and Precigen Inc were among the major stocks that saw significant gains on Thursday. Olaplex surged 51% following its acquisition agreement by Henkel AG for $1.4 billion, while Kodiak Sciences jumped after announcing positive Phase 3 study results. Precigen also saw a notable increase after reporting better-than-expected quarterly earnings.
Henkel offers Olaplex holders $2.06 a share in $1.4B cash deal
Henkel AG & Co. KGaA has agreed to acquire Olaplex Holdings, Inc. (OLPX) for $2.06 per share in a cash transaction, valuing the company at approximately $1.4 billion. This represents a significant premium of about 55% over Olaplex's closing stock price on March 25, 2026. The deal is expected to close in the second half of 2026, pending regulatory approvals, and Olaplex will continue to operate under its existing brand but will be delisted from Nasdaq.
Olaplex Holdings Inc. has officially announced that its shares will be delisted from the Nasdaq Stock Exchange.
Olaplex Holdings Inc. announced its delisting from the Nasdaq Stock Exchange. Concurrently, private equity firm Advent International will fully divest its investments in Olaplex. This move signifies a significant change in the company's capital structure and shareholder makeup.
Henkel AG & Co. KGaA entered into a definitive agreement to acquire Olaplex Holdings, Inc. from Advent International, L.P. and others for approximately $1.4 billion.
Henkel AG & Co. KGaA has entered into a definitive agreement to acquire Olaplex Holdings, Inc. for approximately $1.4 billion, paying $2.06 per share. Upon completion, Olaplex will continue to operate under its current name and brand but will be delisted from Nasdaq, with Advent International fully exiting its investment. The transaction, approved by Olaplex's board and Advent International, is expected to close in the second half of 2026.
If You Invested $1,000 in Olaplex Holdings, Inc. (OLPX)
This article analyzes the historical performance of a $1,000 investment in Olaplex Holdings, Inc. (OLPX), detailing current valuations based on 1-year, 5-year, and 10-year investment periods. It highlights the company's business model as a science-enabled haircare brand, its omnichannel distribution, and its strategic focus on bond-building technology and innovation. The article also provides key financial characteristics and frequently asked questions about OLPX's investment returns.
Morgan Stanley Reiterates Olaplex Holdings (OLPX) With a Hold Rating
Morgan Stanley has reiterated an Equalweight rating for Olaplex Holdings (OLPX) with a price target of $1.40, following the company's fiscal Q4 2025 earnings report. Despite beating revenue expectations, EPS met consensus, and the company provided a softer 2026 guidance. The report notes Morgan Stanley's reduced adjusted EBITDA estimates for 2026 and 2027 due to low visibility in sustained topline growth, while also highlighting the potential of AI stocks.
Olaplex (OLPX) counsel sells 34,962 shares to cover RSU tax bill
Olaplex Holdings, Inc.'s General Counsel, John C. Duffy, sold 34,962 shares of common stock at $1.26 per share. This was a "sell to cover" transaction to meet tax withholding obligations related to the vesting of restricted stock units (RSUs). Following the sale, Mr. Duffy still beneficially owned 982,855 shares, indicating a continued significant equity stake in the company.
OLAPLEX (OLPX) CEO sells 451,837 shares in tax-related RSU transaction
OLAPLEX HOLDINGS, INC. CEO Amanda Baldwin sold 451,837 shares of common stock at $1.17 per share to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). This "sell to cover" transaction is a routine administrative event, not a discretionary change in investment. After the sale, Baldwin still directly holds 9,129,515 shares of common stock.
Olaplex (OLPX) Chief People Officer sells shares to cover RSU tax withholding
Olaplex's Chief People Officer, Trisha L. Fox, sold 25,421 shares of the company's common stock at $1.26 per share. This transaction was specifically to cover tax withholding obligations stemming from the vesting of restricted stock units (RSUs), a common "sell to cover" practice. Following this sale, Fox directly retains 1,080,363 shares of Olaplex common stock, indicating a substantial ongoing equity position.
Olaplex (OLPX) CFO sells 93,809 shares to cover RSU tax withholding
Olaplex Holdings, Inc.'s COO and CFO, Catherine Dunleavy, sold 93,809 shares of common stock at $1.26 per share. This transaction was solely to cover tax withholding obligations related to the vesting of restricted stock units (RSUs) through a "sell to cover" mechanism. After the sale, Dunleavy directly holds 3,026,885 shares, indicating it was a non-discretionary, tax-related sale rather than a change in her investment strategy.
Olaplex Holdings CEO Amanda Baldwin Sells Shares to Cover Tax Obligations
Olaplex Holdings CEO Amanda Baldwin sold 451,837 shares of common stock for $1.17 per share, totaling $528,649. This transaction on March 13, 2026, was conducted to cover tax withholding obligations from restricted stock units. Following the sale, Amanda Baldwin now directly owns 9,129,515 shares of Olaplex Holdings.
Portolan Capital Boosts Stake in Olaplex Holdings
Portolan Capital Management LLC has significantly increased its stake in Olaplex Holdings, Inc. by 132.6% in the third quarter of 2025, now owning approximately 3.6 million shares. This move signals continued confidence in Olaplex's business model and long-term prospects within the beauty and personal care industry. The investment firm's substantial increase in ownership highlights Olaplex's attractiveness as a long-term opportunity due to its innovative product line and growth potential.
Portolan Capital Management LLC Raises Holdings in Olaplex Holdings, Inc. $OLPX
Portolan Capital Management LLC significantly increased its stake in Olaplex Holdings, Inc. ($OLPX) by 132.6% in Q3, now owning 3.6 million shares valued at $4.76 million. Despite this increase, other institutional investors have also adjusted their positions, and analysts are mixed on Olaplex, assigning a consensus "Hold" rating with an average target price of $1.88. The company recently reported Q4 earnings in line with estimates, but the stock trades near $1.20, shows a negative P/E, and has seen recent insider selling.
[144] OLAPLEX HOLDINGS, INC. SEC Filing
This SEC filing (Form 144) for OLAPLEX HOLDINGS, INC. (OLPX) details the proposed sale of 89,529 shares of common stock by an individual, acquired through restricted stock units as compensation. The aggregate market value of these shares is $117,282.99, and the sale is anticipated to occur on 03/12/2026 on NASDAQ. The filing indicates a neutral impact and sentiment according to Rhea-AI.
Olaplex Holdings, Inc. (OLPX) Q4 earnings and revenues top estimates
This article is a placeholder with a title indicating that Olaplex Holdings, Inc. (OLPX) reported better-than-expected Q4 earnings and revenues. There is no actual content provided to detail these financial results or give further context.
Olaplex (NASDAQ: OLPX) GC awarded RSUs, sells shares to cover tax
Olaplex's General Counsel, John C. Duffy, recently engaged in two significant stock transactions. He sold 34,824 shares of common stock for $1.26 per share to cover tax obligations related to vesting restricted stock units (RSUs). Additionally, he received a new grant of 384,615 RSUs, which will vest in four equal annual installments between 2027 and 2030, contingent on his continued employment.
Olaplex insider sells $33,000 in shares
Olaplex insider Trisha Fox sold 26,426 shares of the company's stock for over $33,000 on March 9th, 2026. This transaction reduced Fox's ownership stake by 3.53%, though the article notes that a single insider sale doesn't necessarily indicate broader issues for the company. Investors are advised to monitor future financial performance and insider ownership changes.
Earnings call transcript: Olaplex Holdings Q4 2025 results show mixed performance
Olaplex Holdings reported mixed Q4 2025 results, with an EPS of $0.01 significantly beating forecasts but revenue of $105.1 million falling slightly short. The stock experienced a pre-market decline of 17.98% despite the EPS beat, reflecting investor concerns over the revenue miss and increased operational expenses. The company outlined strategic priorities for 2026, focusing on energizing hero products, fueling science-based innovation, and expanding its diversified go-to-market model to drive sustainable long-term growth.
Olaplex earnings on deck: Can new products reverse declines?
Olaplex is set to report fourth-quarter earnings, with investors focused on whether new product launches can reverse revenue declines and improve profitability. Analysts forecast muted results, but recent product innovations and potential takeover speculation offer intrigue. The upcoming report will determine if the company's turnaround efforts are gaining traction.
Olaplex Holdings Hits Day Low of $1.22 Amid Price Pressure
Olaplex Holdings, Inc. experienced significant stock volatility, hitting an intraday low of $1.22 and declining 17.7% for the day. The company has seen downturns over the past week and month, underperforming the S&P 500 over the last year. Financial metrics reveal ongoing challenges, including a negative net profit of -USD 6.07 million.
Olaplex (OLPX) Q4 2025 Revenue Grows 4% to $105.1M Despite EPS Miss
Olaplex (OLPX) reported Q4 2025 revenue of $105.1M, a 4% year-over-year increase, despite an adjusted EPS miss of $0.01. The company achieved full-year 2025 net sales of $423 million, stabilizing after previous declines, driven by a brand relaunch and increased earned media value, alongside strategic acquisitions and re-engagement with professional stylists. Olaplex plans to launch No. 3+ for 2026, anticipating demand in H2 and affirming confidence in long-term growth despite expected Q1 EBITDA pressure from marketing costs.
Earnings call transcript: Olaplex Holdings Q4 2025 results show mixed performance
Olaplex Holdings reported mixed Q4 2025 results, with an EPS of $0.01 significantly exceeding forecasts but revenue falling slightly short at $105.1 million. Despite a 17.98% pre-market stock drop, the company saw strong performance in professional and direct-to-consumer channels, stabilizing net sales for the year 2025. Olaplex is focused on accelerating its "Bonds and Beyond" strategy in 2026 through hero product revitalization, science-based innovation, and an expanded go-to-market model.
Olaplex (OLPX) Returns To Quarterly Profit As Turnaround Narratives Face New Test
Olaplex (OLPX) has reported a return to quarterly profit in Q3 FY 2025 with net income of US$11.1 million, despite still being loss-making on a trailing twelve-month basis. The company faces mixed signals, with its premium P/S ratio contrasting with revenue softness and volatile earnings, yet analyst targets and DCF fair value suggest potential upside above the current share price. The results raise questions about the sustainability of margin rebuilding and whether the latest profit signals a stable turnaround.
Olaplex Holdings, Inc. (NASDAQ:OLPX) Q4 2025 Earnings Call Transcript
Olaplex Holdings, Inc. (OLPX) reported its Q4 and full-year 2025 earnings, delivering on financial expectations with flat net sales of $423 million and a strong adjusted EBITDA margin of 22.2%. The company saw encouraging fourth-quarter revenue growth of 4% and outperformed adjusted EBITDA expectations, driven by strategic transformational goals including brand demand generation, innovation, and execution excellence. For 2026, Olaplex aims to energize hero products, fuel science-based innovation, and expand its go-to-market model, anticipating sequential improvement in sell-through despite a projected softer Q1 due to strategic launch phasing and marketing investments.
